本文關(guān)鍵詞： 胃癌 GPR124 臨床意義　出處：《南華大學(xué)》2015年碩士論文　論文類(lèi)型：學(xué)位論文

【摘要】：目的:檢測(cè)GPR124在胃癌組織中的表達(dá)情況,分析其臨床病理意義,為胃癌的早期診斷和分子靶向藥物治療提供有價(jià)值的參考。方法:收集20例胃癌、癌旁組織和正常組織的新鮮標(biāo)本,提取組織蛋白和總RNA,分別運(yùn)用Western blot和RT-PCR檢測(cè)GPR124蛋白和RNA在上述不同組織中的表達(dá)情況。同時(shí)收集不同分化腺癌、非典型增生、正常胃組織石蠟標(biāo)本共99例,運(yùn)用免疫組織化學(xué)染色檢測(cè)不同胃組織中GPR124蛋白的陽(yáng)性率。分析GPR124蛋白在不同胃組織中表達(dá)的差別及意義。結(jié)果:1、Western blot檢測(cè)結(jié)果:GPR124蛋白在胃癌組織中的表達(dá)明顯高于癌旁組織和正常組織(P0.05),癌旁組織也高于正常組織(P0.05)。2、RT-PCR檢測(cè)結(jié)果:GPR124在胃癌組織中的表達(dá)明顯高于癌旁組織和正常組織(P0.05),癌旁組織也高于正常組織(P0.05)。3、免疫組化染色檢測(cè)結(jié)果:GPR124蛋白主要表達(dá)于胞膜,在胃癌組織、非典型增生組織、正常組織的陽(yáng)性表達(dá)率分別為77.78%(49/63)、30.77%(4/13)、4.35%(1/23)。GPR124蛋白在癌組織中的陽(yáng)性表達(dá)率顯著高于非典型增生組織和正常組織(P0.05),非典型增生組織的陽(yáng)性表達(dá)率表達(dá)高于正常組織(P0.05);另外,GPR124蛋白在高分化、中分化、低分化胃癌組織中的陽(yáng)性表達(dá)率分別為33.33%(4/12)、75.00%(15/20)、96.77%(30/31),三組比較均有統(tǒng)計(jì)學(xué)意義(P0.05);III~IV期胃癌的陽(yáng)性表達(dá)率明顯高于I~II期,伴淋巴結(jié)轉(zhuǎn)移胃癌的陽(yáng)性表達(dá)率也明顯高于無(wú)轉(zhuǎn)移者。結(jié)論:1、GPR124蛋白在胃癌組織中表達(dá)上調(diào)。2、GPR124蛋白的表達(dá)水平與胃癌的分化程度、臨床病理分期及是否伴淋巴結(jié)轉(zhuǎn)移有關(guān)。
[Abstract]:Objective: to detect the expression of GPR124 in gastric cancer and analyze its clinicopathological significance, and to provide valuable reference for early diagnosis and molecular targeted drug therapy of gastric cancer. Methods: 20 cases of gastric cancer were collected. Tissue proteins and total RNA were extracted from fresh specimens of paracancerous tissues and normal tissues. Western blot and RT-PCR were used to detect the expression of GPR124 protein and RNA in different tissues, and different differentiated adenocarcinoma and atypical hyperplasia were collected. There were 99 cases of paraffin wax in normal gastric tissue. Immunohistochemical staining was used to detect the positive rate of GPR124 protein in different gastric tissues. The difference and significance of the expression of GPR124 protein in different gastric tissues were analyzed. Results: 1. The results of Western blot analysis showed that the expression of GPR124 protein in gastric cancer was significantly higher than that in paracancerous tissues and normal tissues (P0.05). The expression of TGPR124 in gastric cancer tissues was significantly higher than that in adjacent tissues and normal tissues (P0.05). The results of immunohistochemical staining showed that the protein of 1% GPR124 was mainly expressed in the cell membrane, and in gastric cancer tissue and atypical hyperplasia tissue. The positive expression rates in normal tissues were 77.78% and 30.77%, respectively. The positive expression rate of GPR124 protein in cancer tissues was significantly higher than that in atypical hyperplasia tissues and normal tissues (P0.05). The positive expression rate in atypical hyperplasia tissues was higher than that in normal tissues. In addition, the positive expression rates of GPR124 protein in well-differentiated, moderately differentiated and poorly differentiated gastric cancer tissues were 33.33 / 12 / 75.00 / 20 respectively. 96.7777% 30% 31%, all the three groups had statistical significance (P 0.05). The positive expression rate of gastric cancer in III~IV stage was significantly higher than that in stage II, and the positive expression rate of gastric carcinoma with lymph node metastasis was significantly higher than that in patients without metastasis. Conclusion: 1. The expression of GPR124 protein in gastric carcinoma was related to the degree of differentiation, clinicopathologic stage and lymph node metastasis.
【學(xué)位授予單位】：南華大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2015
【分類(lèi)號(hào)】：R735.2

【共引文獻(xiàn)】

相關(guān)期刊論文 前10條

1 馬來(lái)陽(yáng);孫鵬飛;;雙能量CT在胃癌影像評(píng)價(jià)中的臨床研究進(jìn)展[J];國(guó)際醫(yī)學(xué)放射學(xué)雜志;2015年01期

2 Luca Saragoni;;Upgrading the definition of early gastric cancer: better staging means more appropriate treatment[J];Cancer Biology & Medicine;2015年04期

3 王軍;董衛(wèi)國(guó);郭緒峰;季夢(mèng)遙;;EGF61基因多態(tài)性與胃癌易感性Meta分析[J];中華腫瘤防治雜志;2014年02期

4 薛文;;青年胃癌患者臨床病理特點(diǎn)及長(zhǎng)期生存率[J];齊齊哈爾醫(yī)學(xué)院學(xué)報(bào);2014年09期

5 張棟棟;劉會(huì)玲;范維;王玉鳳;陳小蕓;郭鈺珍;;慢病毒介導(dǎo)的α-烯醇化酶基因沉默對(duì)宮頸癌細(xì)胞化療藥物敏感性的影響[J];世界科技研究與發(fā)展;2014年04期

6 張冬志;陳泉;王曉鵬;蔡輝;張浩軍;;他汀類(lèi)藥物對(duì)胃癌預(yù)防效果的系統(tǒng)評(píng)價(jià)[J];中國(guó)全科醫(yī)學(xué);2015年22期

7 彭敦發(fā);;彌漫型胃癌的分子發(fā)生學(xué)研究進(jìn)展[J];皖南醫(yī)學(xué)院學(xué)報(bào);2013年05期

8 張曄;曲秀娟;劉云鵬;徐玲;趙明芳;侯科佐;滕月娥;;靶向沉默caveolin-1基因?qū)ξ赴┠退幖?xì)胞增殖和遷移影響[J];世界華人消化雜志;2013年32期

9 Ana Isabel Lopes;Filipa F Vale;Mónica Oleastro;;Helicobacter pylori infection- recent developments in diagnosis[J];World Journal of Gastroenterology;2014年28期

10 Danilo do Rosário Pinheiro;Wallax Augusto Silva Ferreira;Mariceli Baia Le嗾o Barros;Mariana Diniz Araújo;Symara Rodrigues-Antunes;Bárbara do Nascimento Borges;;Perspectives on new biomarkers in gastric cancer: Diagnostic and prognostic applications[J];World Journal of Gastroenterology;2014年33期

相關(guān)博士學(xué)位論文 前5條

1 楊梅;NAIF1基因在胃癌細(xì)胞中的功能與機(jī)理研究[D];北京協(xié)和醫(yī)學(xué)院;2013年

2 王凱;單純性室間隔缺損的血漿差異蛋白質(zhì)組學(xué)研究[D];天津醫(yī)科大學(xué);2014年

3 羅柏花;EGFL7誘導(dǎo)EMT促進(jìn)胃癌細(xì)胞侵襲和轉(zhuǎn)移機(jī)制的研究[D];中南大學(xué);2014年

4 李綺雯;胃癌輔助放化療預(yù)后預(yù)測(cè)因素及營(yíng)養(yǎng)狀態(tài)與治療耐受性關(guān)系的研究[D];復(fù)旦大學(xué);2013年

5 曹衛(wèi)國(guó);microRNA-34a在胃癌細(xì)胞中的作用及其調(diào)控機(jī)制的研究[D];上海交通大學(xué);2014年

，

本文編號(hào)：1485454